INTERNATIONAL PATENT: JANSSEN PHARMACEUTICA NV FILES APPLICATION FOR "SELTOREXANT FOR USE IN TREATING MAJOR DEPRESSIVE DISORDER WITH INSOMNIA SYMPTOMS"

GENEVA, Dec. 1 -- JANSSEN PHARMACEUTICA NV (Turnhoutseweg 302340 Beerse) filed a patent application (PCT/EP2025/064242) for "SELTOREXANT FOR USE IN TREATING MAJOR DEPRESSIVE DISORDER WITH INSOMNIA SYMPTOMS" on May 23, 2025. With publication no. WO/2025/242852, the details related to the patent application was published on Nov 27, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BEVANS, Katherine (Janssen Global Services, LLC700 Route 202 SouthRaritan, New Jersey 08628), PANDINA, Gahan (Janssen Research & Development, LLC920 US Route 202Raritan, New Jersey 08869), XU, Haiyan (Janssen Research ...